Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 483

    1.

    Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.

    Stades AM, Hoekstra JB, van den Tweel I, Erkelens DW, Holleman F; STABILITY Study Group.

    Diabetes Care. 2002 Apr;25(4):712-7.PMID: 11919130 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

    Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

    Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

    Clin Ther. 2004 May;26(5):724-36.PMID: 15220016 [PubMed - indexed for MEDLINE]Related articles

    5.

    Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.

    Ahmed AB, Mallias J, Home PD.

    Diabetes Care. 1998 Jul;21(7):1162-6.PMID: 9653613 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.

    Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.

    Diabet Med. 2004 Nov;21(11):1213-20.PMID: 15498088 [PubMed - indexed for MEDLINE]Related articles

    7.

    Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.

    Ahmed AB, Home PD.

    Diabetes Care. 1998 Oct;21(10):1707-13.PMID: 9773735 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

    Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1999 Mar;22(3):468-77.PMID: 10097931 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.

    Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL, Dunger DB.

    Diabetes Care. 2003 Mar;26(3):799-804.PMID: 12610040 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.

    Fulcher GR, Gilbert RE, Yue DK.

    Intern Med J. 2005 Sep;35(9):536-42.PMID: 16105155 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections.

    Colombel A, Murat A, Krempf M, Kuchly-Anton B, Charbonnel B.

    Diabet Med. 1999 Apr;16(4):319-24.PMID: 10220206 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).

    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.

    Endocr J. 2007;54(6):975-83. Epub 2007 Nov 14.PMID: 18000343 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

    Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

    Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112. PMID: 15823767 [PubMed - indexed for MEDLINE]Related articles

    16.

    A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.

    Hamann A, Matthaei S, Rosak C, Silvestre L; HOE901/4007 Study Group.

    Diabetes Care. 2003 Jun;26(6):1738-44.PMID: 12766103 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.

    Sargin H, Sargin M, Altuntaş Y, Sengül AM, Orbay E, Seber S, Uçak S, Yayla A.

    Diabetes Res Clin Pract. 2003 Nov;62(2):79-86.PMID: 14581144 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin glargine: a systematic review of a long-acting insulin analogue.

    Wang F, Carabino JM, Vergara CM.

    Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.PMID: 12860485 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data